Compare Lustrum:K Pharma,Inc.:4896

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index K Pharma,Inc. 4896 Medicals 東証グロース December 1, 2000 2023.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

K Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Balance Sheet 2023年12月期 K Pharma,Inc. Balance Sheet 2022年12月期 K Pharma,Inc. Balance Sheet 2021年12月期 K Pharma,Inc. Balance Sheet 2020年12月期 K Pharma,Inc. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents
(Percent)
3,266up
(98.6%)up
1,337up
(97.3%)up
189
(91.7%)
189
(91.7%)

-
Other Current AssetsHelp
(Percent)
43up
(1.3%)down
34up
(2.5%)down
16
(7.7%)
16
(7.7%)

-
Tangible Fixed AssetsHelp
(Percent)

-

-

-

-

-
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-

-
Investments and OthersHelp
(Percent)
5up
(0.1%)down
4up
(0.3%)down
1
(0.5%)
1
(0.5%)

-
Total AssetsHelp
(Percent)
3,314
(100%)
1,375
(100%)
206
(100%)
206
(100%)
-
(100%)
Total Current LiabilitiesHelp
(Percent)
209up
(6.3%)up
38up
(2.8%)down
27
(13.1%)
27
(13.1%)

-
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-

-
Shareholder's EquityHelp
(Percent)
3,105up
(93.7%)down
1,336up
(97.2%)up
179
(86.9%)
179
(86.9%)

-
Total LiabilitiesHelp
(Percent)
3,314
(100%)
1,375
(100%)
206
(100%)
206
(100%)
-
(100%)

K Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Profit and Loss Account 2023年12月期 K Pharma,Inc. Profit and Loss Account 2022年12月期 K Pharma,Inc. Profit and Loss Account 2021年12月期 K Pharma,Inc. Profit and Loss Account 2020年12月期 K Pharma,Inc. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales
(Percent)
1,000
(100%)
0
(100%)
0
(100%)
0
(100%)
-
(100%)
Total Sales
(Percent)
1,000
(100%)
0
(100%)
0
(100%)
0
(100%)
-
(100%)
Cost of SalesHelp
(Percent)

-

-
90

-

-
Other Costs and RevenueHelp 740up
(74.0%)
392up
139down
229

-
Total CostsHelp 740 392 229 229 -
Net RevenueHelp
-

-
-90

-

-
Earnings Before TaxHelp 301up
(30.1%)
-391down
-229
-229

-
Net IncomeHelp 260up
(26.0%)
-392down
-229
-229

-
当期純利益 260 -392 -229 -229 -

K Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Cash Flow Statement 2023年12月期 K Pharma,Inc. Cash Flow Statement 2022年12月期 K Pharma,Inc. Cash Flow Statement 2021年12月期 K Pharma,Inc. Cash Flow Statement 2020年12月期 K Pharma,Inc. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
454up
(23.4%)up
-363down
(-23.5%)up
-196
(-53.3%)
-196
(-53.3%)

-
Investing Cash Flow(ICF)Help
(Percent)
-11up
(-0.6%)up
-33down
(-2.1%)down
-0
(-0.1%)
-0
(-0.1%)

-
Financing Cash FlowHelp
(Percent)
1,486down
(76.6%)down
1,544up
(100.0%)
368
(100.0%)
368
(100.0%)

-
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-

-
Net Increase and Decrease in Cash and Cash Equivalentsn 1,930up
(99.4%)up
1,148up
(74.3%)up
172
(46.6%)
172
(46.6%)

-

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

K Pharma,Inc.

Company where related level is highHelp

Eisai Co.,Ltd.
SSP CO.,LTD.
Cuorips Inc.
KYORIN Pharmaceutical Co., Ltd.
Astellas Pharma Inc.
RIBOMIC Inc.
TSUMURA & CO.
Fuji Pharma Co.,Ltd.
StemRIM Inc.
Oncolys BioPharma Inc.